Cargando…
Ambulatory COVID-19 Patients Treated with Lactoferrin as a Supplementary Antiviral Agent: A Preliminary Study
SARS-CoV-2, an enveloped, single-stranded RNA virus causing COVID-19, exerts morbidity and mortality especially in elderly, obese individuals and those suffering from chronic conditions. In addition to the availability of vaccines and the limited efficacy of the first dose of vaccine against SARS-Co...
Autores principales: | Rosa, Luigi, Tripepi, Giovanni, Naldi, Enrico, Aimati, Marina, Santangeli, Stefano, Venditto, Francesco, Caldarelli, Marcello, Valenti, Piera |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469309/ https://www.ncbi.nlm.nih.gov/pubmed/34575388 http://dx.doi.org/10.3390/jcm10184276 |
Ejemplares similares
-
Lactoferrin as Antiviral Treatment in COVID-19 Management: Preliminary Evidence
por: Campione, Elena, et al.
Publicado: (2021) -
Antiviral Properties of Lactoferrin—A Natural Immunity Molecule
por: Berlutti, Francesca, et al.
Publicado: (2011) -
Lactoferrin in Aseptic and Septic Inflammation
por: Lepanto, Maria Stefania, et al.
Publicado: (2019) -
An overview on in vitro and in vivo antiviral activity of lactoferrin: its efficacy against SARS-CoV-2 infection
por: Rosa, Luigi, et al.
Publicado: (2022) -
To Boost or to Reset: The Role of Lactoferrin in Energy Metabolism
por: Ianiro, Giusi, et al.
Publicado: (2023)